Michael Hayden
2015
In 2015, Michael Hayden earned a total compensation of $6.1M as Former President of Global R&D and Chief Scientific Officer at Teva Pharmaceutical Industries.
Compensation breakdown
| Bonus | $500,000 |
|---|---|
| Non-Equity Incentive Plan | $1,608,239 |
| Option Awards | $950,034 |
| Salary | $1,050,000 |
| Stock Awards | $949,967 |
| Other | $1,045,992 |
| Total | $6,104,232 |
Hayden received $1.6M in non-equity incentive plan, accounting for 26% of the total pay in 2015.
Hayden also received $500K in bonus, $950K in option awards, $1.1M in salary, $950K in stock awards and $1M in other compensation.
Rankings
In 2015, Michael Hayden's compensation ranked 1,209th out of 13,638 executives tracked by ExecPay. In other words, Hayden earned more than 91.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,209 out of 13,638 | 91st |
Division Manufacturing | 426 out of 5,187 | 92nd |
Major group Chemicals And Allied Products | 155 out of 1,857 | 92nd |
Industry group Drugs | 118 out of 1,531 | 92nd |
Industry Pharmaceutical Preparations | 97 out of 1,179 | 92nd |
Source: SEC filing on April 25, 2018.
Hayden's colleagues
We found three more compensation records of executives who worked with Michael Hayden at Teva Pharmaceutical Industries in 2015.